Clinical trial
Intranasal Insulin for Prevention of Type 1 Diabetes
NCT00223613 · University of Turku, Other · Unknown status
Key facts
| NCT number | NCT00223613 |
|---|---|
| Title | Intranasal Insulin for Prevention of Type 1 Diabetes |
| Official title | Intranasal Insulin for Prevention of Type 1 Diabetes in Children Carrying Increased HLA-Conferred Genetic Risk |
| Lead sponsor | University of Turku, Other |
| Collaborators | Oulu University Hospital Tampere University University of Helsinki |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes |
| Intervention type | Drug |
| Interventions | daily intranasal administration of insulin |
| Enrollment | 240 |
| Start date | Aug 1, 1997 |
| Completion | Aug 1, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | Sep 19, 2006 |
| Countries | Finland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: